Straight to content
Foto van risastla / spreekgestoelte

Overpriced drugs: SOMO and Wemos publication discussed in Dutch parliament

Published on:

Recently, SOMO and Wemos published their research into the extent of Dutch public funding for drug development, through donations, loans and/or investments. The publication, Overpriced, reveals that because no conditions are set on these investments, the Government loses its chance to curb subsequent high drug prices. SOMO and Wemos argue the need for European legislation to ensure affordable medicines and a public return on public investment.

Overpriced drugs developed with tax money

Various national media outlets have covered the publication and Dutch politicians, Van Gerven (SP) and Ellemeet (GroenLinks), have used it to question the Minister for Medical Care and Sports, Bruno Bruins (VVD).

Want to know more? Read the full story here in Dutch.

Do you need more information?

Published on:

Related news

Don't want to miss anything?

Sign up for our newsletter and always stay up to date on information and analysis on corporate power issues.